Swampscott, MA, United States of America

Aleksey Lomakin

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aleksey Lomakin: Innovator in Molecular Tweezers for Amyloid-Related Diseases

Introduction

Aleksey Lomakin is a notable inventor based in Swampscott, MA (US). He has made significant contributions to the field of biomedical research, particularly in the treatment of amyloid-related diseases. His innovative approach has the potential to impact the lives of many individuals affected by these conditions.

Latest Patents

Lomakin holds a patent for his invention titled "Molecular tweezers for the treatment of amyloid-related diseases." This invention provides novel compositions designed to inhibit the aggregation of amyloid proteins. In various embodiments, the compositions comprise molecular tweezers that bind lysine and/or arginine, thereby inhibiting the aggregation of amyloidogenic proteins. He has 1 patent to his name.

Career Highlights

Throughout his career, Lomakin has worked with prestigious institutions, including the University of California and the United States Government as represented by the Department of Veterans Affairs. His work has been instrumental in advancing the understanding and treatment of amyloid-related diseases.

Collaborations

Lomakin has collaborated with esteemed colleagues such as Gal Bitan and Akila Shanmugam. Their combined expertise has contributed to the development of innovative solutions in the field of amyloid research.

Conclusion

Aleksey Lomakin's contributions to the field of biomedical research, particularly through his patent on molecular tweezers, highlight his role as an innovator in the treatment of amyloid-related diseases. His work continues to pave the way for advancements in this critical area of health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…